05/14/2025
4:28 PM | OncoCyte (Filer)
| Form ARS | |
05/14/2025
4:07 PM | OncoCyte (Filer)
| Form DEF 14A | |
05/14/2025
4:08 PM | OncoCyte (Filer)
| Form DEFA14A | |
04/17/2025
4:17 PM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/07/2025
11:15 PM | OncoCyte (Filer)
| Form EFFECT | |
04/08/2025
5:10 AM | OncoCyte (Filer)
| Form 424B3 | |
03/31/2025
12:25 PM | OncoCyte (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/24/2025
3:10 PM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
3:16 PM | OncoCyte (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2025
6:06 PM | BIO-RAD LABORATORIES, INC. (Filed by)
BIO-RAD LABORATORIES, INC. (Filed by)
OncoCyte (Subject)
| Form SCHEDULE 13G/A | |
02/24/2025
5:03 AM | OncoCyte (Filer)
| Form D
Notice of Exempt Offering of Securities | |
Get the Latest News and Ratings for OCX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter. |
02/14/2025
1:41 PM | AWM Investment Company, Inc. (Filed by)
OncoCyte (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
6:00 PM | James Andrea S. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
7:46 PM | BROADWOOD PARTNERS, L.P. (Filed by)
OncoCyte (Subject)
| Form SCHEDULE 13D/A | |
02/10/2025
7:43 PM | BRADSHER NEAL C (Reporting)
BROADWOOD CAPITAL INC (Reporting)
BROADWOOD PARTNERS, L.P. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
8:03 AM | OncoCyte (Filer)
| Form 424B5 | |
02/10/2025
8:17 AM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2025
4:00 PM | OncoCyte (Issuer)
SMITH PATRICK W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
4:00 PM | OncoCyte (Issuer)
SMITH PATRICK W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
3:05 PM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2024
8:58 PM | OncoCyte (Subject)
SMITH PATRICK W (Filed by)
| Form SCHEDULE 13G/A | |
12/27/2024
8:42 PM | OncoCyte (Issuer)
SMITH PATRICK W (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/27/2024
8:49 PM | OncoCyte (Issuer)
SMITH PATRICK W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
5:17 PM | Arno Andrew (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
4:30 PM | OncoCyte (Subject)
SMITH PATRICK W (Filed by)
| Form SC 13G/A | |
12/09/2024
7:00 AM | James Andrea S. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2024
11:13 AM | BIO-RAD LABORATORIES, INC. (Filed by)
BIO-RAD LABORATORIES, INC. (Filed by)
OncoCyte (Subject)
| Form SC 13G/A | |
10/22/2024
3:12 PM | OncoCyte (Filer)
| Form 424B3 | |
10/21/2024
11:15 PM | OncoCyte (Filer)
| Form EFFECT | |
10/18/2024
3:55 PM | OncoCyte (Filer)
| Form S-3/A | |
10/16/2024
4:16 PM | OncoCyte (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/15/2024
3:15 PM | James Andrea S. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:22 PM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
4:03 PM | OncoCyte (Subject)
SMITH PATRICK W (Filed by)
| Form SC 13G | |
10/04/2024
6:40 PM | James Andrea S. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
6:00 PM | BRADSHER NEAL C (Reporting)
BROADWOOD CAPITAL INC (Reporting)
BROADWOOD PARTNERS, L.P. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
5:05 AM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2024
3:09 PM | OncoCyte (Filer)
| Form DEF 14A | |
08/09/2024
5:25 AM | OncoCyte (Filer)
| Form 424B5 | |
08/09/2024
5:37 AM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
11:15 PM | OncoCyte (Filer)
| Form EFFECT | |
AI Meltdown Imminent: Dump These Stocks Now! (Ad) If you have any money in the markets, especially in AI stocks…
Please click here to see Elon Musk’s new invention…
This could send many popular AI stocks crashing, including Nvidia.
And it could happen starting as soon as June 1st. Click here to see the details and learn how to prepare for the next AI revolution |
08/08/2024
3:27 PM | OncoCyte (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/05/2024
3:01 PM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
8:00 PM | OncoCyte (Issuer)
SILVERMAN LOU (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
8:00 PM | Last Andrew J. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
8:00 PM | Arno Andrew (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:47 PM | James Andrea S. (Reporting)
OncoCyte (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/24/2024
3:49 PM | James Andrea S. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
10:26 AM | OncoCyte (Filer)
| Form 424B3 | |
05/22/2024
11:15 PM | OncoCyte (Filer)
| Form EFFECT | |
Buy OCX Stock Free OCX Stock Alerts